SynthesisMedicine2018

Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.

Lunshou Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.